Sector
PharmaceuticalsOpen
₹12.11Prev. Close
₹12.11Turnover(Lac.)
₹1.8Day's High
₹12.11Day's Low
₹12.152 Week's High
₹2752 Week's Low
₹9.29Book Value
₹11.13Face Value
₹10Mkt Cap (₹ Cr.)
24.2P/E
0EPS
0Divi. Yield
029 Aug 2024
12:00 AM
AGM
Announcement Date: 29 Aug, 2024
18 Sep 2023
12:00 AM
Bonus
4 Feb 2025
12:00 AM
Board Meeting
Agenda : Audited Result
29 Aug 2024
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 20 | 10 | 6.93 | 6.93 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1.84 | 11.43 | 7.02 | 7.11 |
Net Worth | 21.84 | 21.43 | 13.95 | 14.04 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 10.57 | 11.72 | 5.16 | 1.91 |
yoy growth (%) | -9.78 | 126.88 | 169.65 | -11.76 |
Raw materials | -7.51 | -7.88 | -3.67 | -1.16 |
As % of sales | 71.04 | 67.21 | 71.15 | 60.54 |
Employee costs | -0.82 | -0.79 | -0.57 | -0.58 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.57 | 0.64 | 0.25 | 0.03 |
Depreciation | -0.46 | -0.32 | -0.27 | -0.22 |
Tax paid | -0.19 | -0.32 | -0.11 | 0 |
Working capital | 0.46 | -1.55 | -1.01 | 1.02 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -9.78 | 126.88 | 169.65 | -11.76 |
Op profit growth | -90.18 | -648.3 | -65.87 | 1,564.22 |
EBIT growth | -5.02 | 160.32 | 142.9 | -15.45 |
Net profit growth | 19.13 | 132.16 | 503.96 | 157.95 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,744.85 | 132.89 | 4,18,647.96 | 1,181.05 | 0.77 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 6,001.1 | 76.85 | 1,59,310.35 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,478.5 | 25.66 | 1,19,409.63 | 1,438.15 | 0.88 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,137.55 | 58.21 | 1,06,184.18 | 485 | 0.89 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,413.35 | 51.49 | 99,569.64 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Director
Shruti Y Shah
Chairman (Non-Executive)
Yogesh M Shah
Managing Director
Bhavin S Shah
Company Sec. & Compli. Officer
Rony M Shah
Independent Director
Chetan H Mehta
Independent Director
Prakash C Shah
Independent Director
Nilesh Kantilal Shah
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Veerhealth Care Ltd
Summary
Veerhealth Care Limited was originally incorporated on 10 July, 1992 as Niyati Leasing Limited to start business in Investment and Finance. The main objects of the Company in 1998 got changed and accordingly the name was changed from Niyati Leasing Limited to Niyati Industries Limited and from Niyati Industries Limited to Veerhealth Care Limited in May, 2013. Initially in 2010, the Company was engaged into dealing and trading of shares, securities, debentures, and other investments. It wanted to start business in the field of infrastructure. Later on, the Company through the Main Objects, diversify the business activities to Pharma sector in 2013. Apart from Tablet, Syrup, Ointment, Powder, it also started manufacturing in the Oil, Shampoo, Ointment and Toothpaste Division in year 2015-16. In 2020, it started operations in cosmetic manufacturing.Further, the Company produces Intensive research based quality products with Expert guidance and enormous experience of renowned Vaid of Mumbai, in formulations of cosmetic and personal care products. Ayuveer is proud of its knowledge of herbs and their uses passed on by its Parent Company, Veerhealth Care involved in manufacturing and supply of ayurvedic medicines and oral care products.
Read More
What is the Veerhealth Care Ltd share price today?
The Veerhealth Care Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹12.1 today.
What is the Market Cap of Veerhealth Care Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Veerhealth Care Ltd is ₹24.20 Cr. as of 12 May ‘25
What is the PE and PB ratio of Veerhealth Care Ltd?
The PE and PB ratios of Veerhealth Care Ltd is 0 and 1.09 as of 12 May ‘25
What is the 52 Week High and Low of Veerhealth Care Ltd?
The 52-week high/low is the highest and lowest price at which a Veerhealth Care Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Veerhealth Care Ltd is ₹9.29 and ₹27 as of 12 May ‘25
What is the CAGR of Veerhealth Care Ltd?
Veerhealth Care Ltd's CAGR for 5 Years at 30.52%, 3 Years at 23.23%, 1 Year at -41.75%, 6 Month at -38.13%, 3 Month at -29.51% and 1 Month at -9.32%.
What is the shareholding pattern of Veerhealth Care Ltd?
The shareholding pattern of Veerhealth Care Ltd is as follows:
Promoters - 31.50 %
Institutions - 0.00 %
Public - 68.50 %
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
